Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zwitter

Showing results (31-40 of 51) with videos related to

Pageof 6
Sort By:
Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.
Anti-Cancer Drugs|October 14, 2005
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancerM Zwitter, V Kovac, U Smrdel, et al.
Radiology and Oncology|July 4, 2014
Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survivalKarmen Stanic, Matjaz Zwitter, Nina Turnsek Hitij, et al.
Journal of Biomedicine & Biotechnology|May 5, 2011
Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trialMatjaz Zwitter, Mirjana Rajer, Viljem Kovac, et al.
Anti-Cancer Drugs|October 27, 2011
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesotheliomaViljem Kovac, Matjaz Zwitter, Mirjana Rajer, et al.
Radiology and Oncology|December 2, 2014
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutationsMatjaz Zwitter, Karmen Stanic, Mirjana Rajer, et al.
Clinical Lung Cancer|January 17, 2017
Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung CancerNina Turnšek Hitij, Izidor Kern, Aleksander Sadikov, et al.
Radiology and Oncology|December 2, 2016
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factorUros Smrdel, Mara Popovic, Matjaz Zwitter, et al.
Cancer Biology & Therapy|June 5, 2016
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutationsMatjaz Zwitter, Mirjana Rajer, Karmen Stanic, et al.
Plant Disease|April 3, 2025
First Report of Watermelon Crinkle Leaf-Associated Virus 1 (WCLaV-1) and WCLaV-2 in Watermelon in SloveniaAna Vučurović, Irena Bajde, Jakob Brodarič, et al.
Pageof 6

Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Radiology and Oncology|September 30, 2017
Selection of Non-small Cell Lung Cancer Patients for Intercalated Chemotherapy and Tyrosine Kinase InhibitorsMatjaz Zwitter, Antonio Rossi, Massimo Di Maio, et al.
Anti-Cancer Drugs|October 14, 2005
Phase I-II trial of low-dose gemcitabine in prolonged infusion and cisplatin for advanced non-small cell lung cancerM Zwitter, V Kovac, U Smrdel, et al.
Radiology and Oncology|July 4, 2014
Brain metastases in lung adenocarcinoma: impact of EGFR mutation status on incidence and survivalKarmen Stanic, Matjaz Zwitter, Nina Turnsek Hitij, et al.
Journal of Biomedicine & Biotechnology|May 5, 2011
Intermittent chemotherapy and erlotinib for nonsmokers or light smokers with advanced adenocarcinoma of the lung: a phase II clinical trialMatjaz Zwitter, Mirjana Rajer, Viljem Kovac, et al.
Anti-Cancer Drugs|October 27, 2011
A phase II trial of low-dose gemcitabine in a prolonged infusion and cisplatin for malignant pleural mesotheliomaViljem Kovac, Matjaz Zwitter, Mirjana Rajer, et al.
Radiology and Oncology|December 2, 2014
Intercalated chemotherapy and erlotinib for advanced NSCLC: high proportion of complete remissions and prolonged progression-free survival among patients with EGFR activating mutationsMatjaz Zwitter, Karmen Stanic, Mirjana Rajer, et al.
Clinical Lung Cancer|January 17, 2017
Immunohistochemistry for EGFR Mutation Detection in Non-Small-Cell Lung CancerNina Turnšek Hitij, Izidor Kern, Aleksander Sadikov, et al.
Radiology and Oncology|December 2, 2016
Long-term survival in glioblastoma: methyl guanine methyl transferase (MGMT) promoter methylation as independent favourable prognostic factorUros Smrdel, Mara Popovic, Matjaz Zwitter, et al.
Cancer Biology & Therapy|June 5, 2016
Intercalated chemotherapy and erlotinib for non-small cell lung cancer (NSCLC) with activating epidermal growth factor receptor (EGFR) mutationsMatjaz Zwitter, Mirjana Rajer, Karmen Stanic, et al.
Plant Disease|April 3, 2025
First Report of Watermelon Crinkle Leaf-Associated Virus 1 (WCLaV-1) and WCLaV-2 in Watermelon in SloveniaAna Vučurović, Irena Bajde, Jakob Brodarič, et al.
Pageof 6